Free Trial
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free FC Stock Alerts

Franklin Covey (FC) Financials

Franklin Covey logo
$20.88 -0.40 (-1.86%)
As of 03:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Franklin Covey

Annual Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 8/31/2022 8/31/2023 8/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 17 17 24
Consolidated Net Income / (Loss)		 18 18 23
Net Income / (Loss) Continuing Operations		 18 18 23
Total Pre-Tax Income 		22 26 33
Total Operating Income		 24 26 33
Total Gross Profit		 202 213 221
Total Revenue		 263 281 287
Operating Revenue		 263 281 287
Total Cost of Revenue		 61 67 66
Operating Cost of Revenue		 61 67 66
Total Operating Expenses		 178 187 188
Selling, General & Admin Expense		 168 178 176
Depreciation Expense		 4.90 4.27 3.91
Amortization Expense		 5.27 4.34 4.25
Impairment Charge		 0.00 0.00 0.93
Restructuring Charge		 0.00 0.57 3.01
Total Other Income / (Expense), net		 -1.61 -0.49 0.00
Interest Expense		 1.68 1.58 1.12
Interest & Investment Income		 0.07 1.09 1.12
Income Tax Expense		 3.63 8.09 9.64
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 1.25 0.45 -0.22
Basic Earnings per Share		 $1.30 $1.30 $1.78
Weighted Average Basic Shares Outstanding		 14.15M 13.64M 13.17M
Diluted Earnings per Share		 $1.27 $1.24 $1.74
Weighted Average Diluted Shares Outstanding		 14.56M 14.30M 13.47M
Weighted Average Basic & Diluted Shares Outstanding		 13.90M 13.43M 13.18M

Quarterly Income Statements for Franklin Covey

This table shows Franklin Covey's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 8/31/2022 11/30/2022 2/28/2023 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025
Net Income / (Loss) Attributable to Common Shareholders		 4.33 4.54 1.89 4.42 6.49 4.90 0.74 5.55 12 0.98 -1.12
Consolidated Net Income / (Loss)		 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18 -1.08
Net Income / (Loss) Continuing Operations		 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18 -1.08
Total Pre-Tax Income 		8.28 6.06 2.78 6.58 10 5.28 1.42 8.36 18 1.59 -1.35
Total Operating Income		 8.66 6.39 2.83 6.57 11 5.33 1.44 8.34 18 1.48 -1.46
Total Gross Profit		 59 53 47 54 59 52 47 56 66 53 46
Total Revenue		 79 69 62 71 78 68 61 73 84 69 60
Operating Revenue		 79 69 62 71 78 68 61 73 84 69 60
Total Cost of Revenue		 20 17 15 17 19 16 14 17 18 16 14
Operating Cost of Revenue		 20 17 15 17 19 16 14 17 18 16 14
Total Operating Expenses		 50 46 44 48 49 47 45 48 48 51 47
Selling, General & Admin Expense		 48 44 42 46 46 44 41 45 45 47 45
Depreciation Expense		 1.22 1.25 0.95 0.93 1.14 1.09 0.91 0.99 0.91 0.95 1.02
Amortization Expense		 1.16 1.09 1.09 1.09 1.07 1.07 1.07 1.06 1.04 1.10 1.10
Impairment Charge		 - - 0.00 0.00 - - 0.93 0.00 - - 0.00
Restructuring Charge		 - - 0.00 0.00 - 0.58 1.73 0.70 - 1.98 0.00
Total Other Income / (Expense), net		 -0.38 -0.33 -0.05 0.01 -0.12 -0.05 -0.03 0.02 0.06 0.11 0.11
Interest Expense		 0.40 0.41 0.41 0.35 0.41 0.34 0.33 0.25 0.20 0.18 0.16
Interest & Investment Income		 0.02 0.08 0.36 0.36 0.29 0.29 0.30 0.27 0.27 0.29 0.26
Income Tax Expense		 2.70 1.40 1.04 2.02 3.63 0.43 0.54 2.64 6.04 0.41 -0.27
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - 0.13 -0.15 0.14 0.32 -0.05 0.14 0.18 -0.48 0.20 0.04
Basic Earnings per Share		 $0.39 $0.34 $0.13 $0.33 $0.50 $0.37 $0.07 $0.43 $0.91 $0.09 ($0.08)
Weighted Average Basic Shares Outstanding		 14.15M 13.88M 13.90M 13.62M 13.64M 13.24M 13.26M 13.16M 13.17M 13.09M 13.10M
Diluted Earnings per Share		 $0.36 $0.32 $0.12 $0.32 $0.48 $0.36 $0.06 $0.43 $0.89 $0.09 ($0.08)
Weighted Average Diluted Shares Outstanding		 14.56M 14.51M 14.53M 14.27M 14.30M 13.64M 13.48M 13.38M 13.47M 13.27M 13.10M
Weighted Average Basic & Diluted Shares Outstanding		 13.90M 13.91M 13.85M 13.20M 13.43M 13.29M 13.27M 13.09M 13.18M 13.20M 12.99M

Annual Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 8/31/2022 8/31/2023 8/31/2024
Net Change in Cash & Equivalents		 13 -22 10
Net Cash From Operating Activities		 52 36 60
Net Cash From Continuing Operating Activities		 52 36 60
Net Income / (Loss) Continuing Operations		 18 18 23
Consolidated Net Income / (Loss)		 18 18 23
Depreciation Expense		 10 8.61 8.15
Amortization Expense		 4.27 3.92 3.93
Non-Cash Adjustments To Reconcile Net Income		 8.29 13 11
Changes in Operating Assets and Liabilities, net		 11 -7.09 14
Net Cash From Investing Activities		 -5.33 -14 -11
Net Cash From Continuing Investing Activities		 -5.33 -14 -11
Purchase of Property, Plant & Equipment		 -3.18 -4.52 -3.69
Acquisitions		 0.00 0.00 -0.75
Other Investing Activities, net		 -2.15 -9.04 -6.87
Net Cash From Financing Activities		 -33 -44 -39
Net Cash From Continuing Financing Activities		 -33 -44 -39
Repayment of Debt		 -8.72 -17 -9.37
Repurchase of Common Equity		 -24 -36 -31
Issuance of Debt		 0.00 7.50 0.00
Issuance of Common Equity		 1.34 1.54 1.47
Other Financing Activities, net		 -1.43 -0.74 0.00
Effect of Exchange Rate Changes		 - -0.30 0.14
Cash Interest Paid		 1.66 1.50 1.11
Cash Income Taxes Paid		 3.21 3.31 4.21

Quarterly Cash Flow Statements for Franklin Covey

This table details how cash moves in and out of Franklin Covey's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 8/31/2022 11/30/2022 2/28/2023 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025
Net Change in Cash & Equivalents		 8.45 -2.37 -3.03 -16 -1.10 -4.27 6.95 -4.33 12 4.63 -13
Net Cash From Operating Activities		 13 3.02 8.19 15 9.79 17 13 8.17 22 14 -1.37
Net Cash From Continuing Operating Activities		 13 3.02 8.19 15 9.79 17 13 8.17 22 14 -1.37
Net Income / (Loss) Continuing Operations		 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18 -1.08
Consolidated Net Income / (Loss)		 5.58 4.67 1.74 4.56 6.81 4.85 0.87 5.72 12 1.18 -1.08
Depreciation Expense		 2.38 2.34 2.04 2.02 2.21 2.16 1.98 2.05 1.96 2.05 2.12
Amortization Expense		 1.20 1.05 1.01 0.96 0.90 0.89 1.01 1.03 1.00 1.20 1.26
Non-Cash Adjustments To Reconcile Net Income		 2.30 2.74 3.32 3.31 3.16 2.90 2.30 2.83 3.05 2.17 1.35
Changes in Operating Assets and Liabilities, net		 1.27 -7.77 0.08 3.89 -3.30 6.64 6.61 -3.46 3.92 7.55 -5.02
Net Cash From Investing Activities		 -1.87 -2.21 -5.71 -2.47 -3.16 -3.74 -1.75 -2.33 -3.50 -2.75 -2.22
Net Cash From Continuing Investing Activities		 -1.87 -2.21 -5.71 -2.47 -3.16 -3.74 -1.75 -2.33 -3.50 -2.75 -2.22
Purchase of Property, Plant & Equipment		 -1.10 -1.24 -1.40 -0.90 -0.97 -1.07 -0.64 -0.90 -1.08 -1.00 -1.27
Other Investing Activities, net		 -0.78 -0.97 -4.30 -1.56 -2.19 -2.67 -1.10 -1.43 -1.67 -1.43 -0.95
Net Cash From Financing Activities		 -2.01 -2.92 -5.80 -28 -7.59 -18 -3.90 -10 -6.69 -6.58 -9.31
Net Cash From Continuing Financing Activities		 -2.01 -2.92 -5.80 -28 -7.59 -18 -3.90 -10 -6.69 -6.58 -9.31
Repayment of Debt		 -2.00 -2.02 -2.04 -11 -2.08 -2.11 -2.12 -2.98 -2.17 -0.95 -0.96
Repurchase of Common Equity		 - -0.84 -3.83 -25 -5.88 -16 -2.11 -7.43 -4.91 -5.95 -8.70
Issuance of Common Equity		 0.33 0.37 0.37 0.42 0.38 0.36 0.33 0.39 0.39 0.32 0.36
Effect of Exchange Rate Changes		 - - - - -0.14 0.09 -0.18 -0.16 0.40 -0.18 0.00
Cash Interest Paid		 0.36 0.37 0.37 0.42 0.34 0.34 0.28 0.32 0.18 0.14 0.12
Cash Income Taxes Paid		 1.47 0.84 0.77 0.85 0.86 0.82 0.82 1.32 1.24 0.75 5.28

Annual Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 8/31/2022 8/31/2023 8/31/2024
Total Assets		 259 246 262
Total Current Assets		 156 145 160
Cash & Equivalents		 61 38 49
Accounts Receivable		 73 82 86
Inventories, net		 3.53 4.21 4.00
Prepaid Expenses		 4.71 4.40 22
Plant, Property, & Equipment, net		 9.80 10 8.74
Total Noncurrent Assets		 93 91 93
Goodwill		 31 31 31
Intangible Assets		 45 41 38
Noncurrent Deferred & Refundable Income Taxes		 4.69 1.66 0.87
Other Noncurrent Operating Assets		 13 17 23
Total Liabilities & Shareholders' Equity		 259 246 262
Total Liabilities		 176 167 178
Total Current Liabilities		 154 152 162
Short-Term Debt		 5.84 5.84 0.84
Accounts Payable		 11 6.50 7.86
Accrued Expenses		 34 28 32
Customer Deposits		 - 12 17
Current Deferred Revenue		 86 95 101
Other Current Liabilities		 17 3.54 3.11
Total Noncurrent Liabilities		 23 16 16
Long-Term Debt		 7.27 1.54 0.78
Noncurrent Deferred & Payable Income Tax Liabilities		 0.20 2.04 3.13
Other Noncurrent Operating Liabilities		 15 12 12
Total Equity & Noncontrolling Interests		 83 79 83
Total Preferred & Common Equity		 83 79 83
Total Common Equity		 83 79 83
Common Stock		 222 234 233
Retained Earnings		 82 100 123
Treasury Stock		 -220 -254 -272
Accumulated Other Comprehensive Income / (Loss)		 -0.54 -0.99 -0.77

Quarterly Balance Sheets for Franklin Covey

This table presents Franklin Covey's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 5/31/2022 11/30/2022 2/28/2023 5/31/2023 11/30/2023 2/29/2024 5/31/2024 11/30/2024 2/28/2025
Total Assets		 228 237 234 218 219 222 221 240 221
Total Current Assets		 122 136 131 117 117 122 120 139 121
Cash & Equivalents		 52 58 55 39 34 41 37 53 40
Accounts Receivable		 50 57 54 55 60 57 60 61 53
Inventories, net		 3.36 3.48 3.47 4.57 4.12 4.20 4.64 3.83 4.09
Prepaid Expenses		 16 17 19 17 19 20 18 20 23
Plant, Property, & Equipment, net		 9.59 9.47 9.85 9.70 9.52 8.71 8.63 8.73 9.55
Total Noncurrent Assets		 97 92 93 91 92 91 92 92 91
Goodwill		 31 31 31 31 31 31 31 31 31
Intangible Assets		 46 44 43 42 39 38 39 37 36
Noncurrent Deferred & Refundable Income Taxes		 6.27 4.28 3.56 2.27 1.68 1.66 1.64 0.83 0.82
Other Noncurrent Operating Assets		 13 12 16 16 20 20 21 23 23
Total Liabilities & Shareholders' Equity		 228 237 234 218 219 222 221 240 221
Total Liabilities		 153 148 143 143 148 151 149 159 149
Total Current Liabilities		 129 128 125 128 135 138 137 144 134
Short-Term Debt		 5.84 5.84 5.84 5.84 4.59 3.34 2.09 0.84 0.84
Accounts Payable		 8.07 6.88 8.49 7.10 5.67 7.73 6.19 5.96 6.80
Accrued Expenses		 29 23 19 24 21 19 22 24 17
Customer Deposits		 - - - - - - 22 22 20
Current Deferred Revenue		 67 74 74 70 83 82 80 89 88
Other Current Liabilities		 20 17 18 21 20 26 3.81 2.17 1.20
Total Noncurrent Liabilities		 25 20 18 15 14 13 12 16 15
Long-Term Debt		 8.49 6.05 4.82 2.76 1.56 1.58 0.76 0.79 0.80
Noncurrent Deferred & Payable Income Tax Liabilities		 0.38 0.20 0.20 0.20 1.01 1.06 1.85 2.91 2.98
Other Noncurrent Operating Liabilities		 16 14 13 12 11 10 9.61 12 11
Total Equity & Noncontrolling Interests		 75 90 91 75 71 71 72 81 73
Total Preferred & Common Equity		 75 90 91 75 71 71 72 81 73
Total Common Equity		 75 90 91 75 71 71 72 81 73
Common Stock		 219 224 227 230 226 227 230 229 229
Retained Earnings		 76 87 88 93 105 106 111 124 123
Treasury Stock		 -221 -220 -224 -248 -259 -261 -268 -271 -279
Accumulated Other Comprehensive Income / (Loss)		 -0.20 -0.67 -0.53 -0.67 -0.94 -1.08 -1.25 -0.97 -1.01

Annual Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric 2022 2023 2024
Period end date 8/31/2022 8/31/2023 8/31/2024
Growth Metrics		 - - -
Revenue Growth		 17.25% 6.73% 2.39%
EBITDA Growth		 60.50% 2.05% 16.03%
EBIT Growth		 192.24% 11.35% 25.34%
NOPAT Growth		 8.85% -8.37% 29.14%
Net Income Growth		 35.29% -3.52% 31.61%
EPS Growth		 32.29% -2.36% 40.32%
Operating Cash Flow Growth		 13.16% -31.61% 68.61%
Free Cash Flow Firm Growth		 85.32% -83.93% 513.28%
Invested Capital Growth		 -30.93% 35.01% -24.51%
Revenue Q/Q Growth		 3.90% -0.30% 2.20%
EBITDA Q/Q Growth		 11.83% 3.85% 18.98%
EBIT Q/Q Growth		 22.52% 7.79% 28.65%
NOPAT Q/Q Growth		 23.21% 6.13% 27.25%
Net Income Q/Q Growth		 25.72% 7.46% 28.17%
EPS Q/Q Growth		 23.30% 10.71% 30.83%
Operating Cash Flow Q/Q Growth		 -4.75% -7.57% 25.08%
Free Cash Flow Firm Q/Q Growth		 -31.71% -45.46% 47.95%
Invested Capital Q/Q Growth		 -4.85% 9.18% -6.12%
Profitability Metrics		 - - -
Gross Margin		 76.82% 76.10% 76.97%
EBITDA Margin		 14.50% 13.86% 15.71%
Operating Margin		 9.01% 9.40% 11.50%
EBIT Margin		 9.01% 9.40% 11.50%
Profit (Net Income) Margin		 7.01% 6.34% 8.15%
Tax Burden Percent		 83.53% 68.73% 70.82%
Interest Burden Percent		 93.20% 98.13% 100.01%
Effective Tax Rate		 16.47% 31.27% 29.18%
Return on Invested Capital (ROIC)		 45.64% 43.56% 55.79%
ROIC Less NNEP Spread (ROIC-NNEP)		 49.18% 44.42% 55.79%
Return on Net Nonoperating Assets (RNNOA)		 -22.98% -21.53% -26.87%
Return on Equity (ROE)		 22.66% 22.02% 28.93%
Cash Return on Invested Capital (CROIC)		 82.24% 13.76% 83.72%
Operating Return on Assets (OROA)		 9.31% 10.44% 13.02%
Return on Assets (ROA)		 7.24% 7.04% 9.22%
Return on Common Equity (ROCE)		 22.66% 22.02% 28.93%
Return on Equity Simple (ROE_SIMPLE)		 22.25% 22.61% 28.15%
Net Operating Profit after Tax (NOPAT)		 20 18 23
NOPAT Margin		 7.52% 6.46% 8.15%
Net Nonoperating Expense Percent (NNEP)		 -3.54% -0.86% 0.01%
Cost of Revenue to Revenue		 23.18% 23.90% 23.03%
SG&A Expenses to Revenue		 63.94% 63.44% 61.25%
R&D to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 67.81% 66.71% 65.46%
Earnings before Interest and Taxes (EBIT)		 24 26 33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 38 39 45
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 7.96 7.16 6.34
Price to Tangible Book Value (P/TBV)		 97.51 81.39 37.26
Price to Revenue (P/Rev)		 2.51 2.01 1.84
Price to Earnings (P/E)		 38.37 32.50 22.32
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 2.61% 3.08% 4.48%
Enterprise Value to Invested Capital (EV/IC)		 17.28 11.14 13.31
Enterprise Value to Revenue (EV/Rev)		 2.33 1.90 1.67
Enterprise Value to EBITDA (EV/EBITDA)		 16.05 13.69 10.64
Enterprise Value to EBIT (EV/EBIT)		 25.84 20.20 14.53
Enterprise Value to NOPAT (EV/NOPAT)		 30.94 29.39 20.52
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.71 14.90 7.97
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.17 93.02 13.67
Leverage & Solvency		 - - -
Debt to Equity		 0.16 0.09 0.02
Long-Term Debt to Equity		 0.09 0.02 0.01
Financial Leverage		 -0.47 -0.48 -0.48
Leverage Ratio		 3.13 3.13 3.14
Compound Leverage Factor		 2.92 3.07 3.14
Debt to Total Capital		 13.66% 8.57% 1.90%
Short-Term Debt to Total Capital		 6.08% 6.78% 0.99%
Long-Term Debt to Total Capital		 7.58% 1.78% 0.91%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 86.34% 91.43% 98.10%
Debt to EBITDA		 0.34 0.19 0.04
Net Debt to EBITDA		 -1.24 -0.79 -1.04
Long-Term Debt to EBITDA		 0.19 0.04 0.02
Debt to NOPAT		 0.66 0.41 0.07
Net Debt to NOPAT		 -2.40 -1.70 -2.01
Long-Term Debt to NOPAT		 0.37 0.08 0.03
Altman Z-Score		 4.01 4.05 3.94
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 1.01 0.96 0.99
Quick Ratio		 0.87 0.79 0.83
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 36 5.73 35
Operating Cash Flow to CapEx		 1,644.76% 791.54% 1,631.21%
Free Cash Flow to Firm to Interest Expense		 21.27 3.62 31.38
Operating Cash Flow to Interest Expense		 31.20 22.58 53.85
Operating Cash Flow Less CapEx to Interest Expense		 29.30 19.72 50.55
Efficiency Ratios		 - - -
Asset Turnover		 1.03 1.11 1.13
Accounts Receivable Turnover		 3.67 3.63 3.42
Inventory Turnover		 20.23 17.32 16.11
Fixed Asset Turnover		 24.65 28.28 30.60
Accounts Payable Turnover		 6.84 7.72 9.21
Days Sales Outstanding (DSO)		 99.46 100.51 106.70
Days Inventory Outstanding (DIO)		 18.04 21.07 22.66
Days Payable Outstanding (DPO)		 53.35 47.28 39.62
Cash Conversion Cycle (CCC)		 64.15 74.31 89.74
Capital & Investment Metrics		 - - -
Invested Capital		 35 48 36
Invested Capital Turnover		 6.07 6.74 6.85
Increase / (Decrease) in Invested Capital		 -16 12 -12
Enterprise Value (EV)		 612 533 480
Market Capitalization		 659 563 527
Book Value per Share		 $5.98 $5.96 $6.35
Tangible Book Value per Share		 $0.49 $0.52 $1.08
Total Capital		 96 86 85
Total Debt		 13 7.37 1.61
Total Long-Term Debt		 7.27 1.54 0.78
Net Debt		 -47 -31 -47
Capital Expenditures (CapEx)		 3.18 4.52 3.69
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -53 -39 -50
Debt-free Net Working Capital (DFNWC)		 7.92 -0.80 -1.37
Net Working Capital (NWC)		 2.09 -6.63 -2.20
Net Nonoperating Expense (NNE)		 1.34 0.34 -0.00
Net Nonoperating Obligations (NNO)		 -47 -31 -47
Total Depreciation and Amortization (D&A)		 14 13 12
Debt-free, Cash-free Net Working Capital to Revenue		 -20.01% -13.91% -17.42%
Debt-free Net Working Capital to Revenue		 3.01% -0.28% -0.48%
Net Working Capital to Revenue		 0.79% -2.36% -0.77%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $1.30 $1.30 $1.78
Adjusted Weighted Average Basic Shares Outstanding		 14.15M 13.64M 13.17M
Adjusted Diluted Earnings per Share		 $1.27 $1.24 $1.74
Adjusted Weighted Average Diluted Shares Outstanding		 14.56M 14.30M 13.47M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.90M 13.43M 13.18M
Normalized Net Operating Profit after Tax (NOPAT)		 20 19 26
Normalized NOPAT Margin		 7.52% 6.60% 9.12%
Pre Tax Income Margin		 8.39% 9.22% 11.50%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 14.13 16.65 29.53
NOPAT to Interest Expense		 11.81 11.45 20.91
EBIT Less CapEx to Interest Expense		 12.24 13.80 26.23
NOPAT Less CapEx to Interest Expense		 9.91 8.59 17.61
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 129.41% 199.96% 131.39%

Quarterly Metrics And Ratios for Franklin Covey

This table displays calculated financial ratios and metrics derived from Franklin Covey's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 8/31/2022 11/30/2022 2/28/2023 5/31/2023 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 14.30% 13.24% 9.11% 7.96% -1.08% -1.40% -0.68% 2.70% 7.91% 1.00% -2.81%
EBITDA Growth		 49.10% 5.47% -17.52% 0.87% 11.79% -14.27% -24.54% 19.64% 52.61% -43.71% -56.69%
EBIT Growth		 100.90% 15.28% -19.59% 10.47% 22.00% -16.63% -49.01% 26.95% 69.63% -72.32% -200.90%
NOPAT Growth		 189.37% 19.04% -16.84% -40.47% 18.09% -0.42% -49.63% 25.22% 72.85% -77.60% -214.35%
Net Income Growth		 208.69% 22.43% -7.40% -36.29% 22.12% 3.94% -49.74% 25.38% 75.51% -75.65% -223.11%
EPS Growth		 200.00% 18.52% -7.69% -37.25% 33.33% 12.50% -50.00% 34.38% 85.42% -75.00% -233.33%
Operating Cash Flow Growth		 -17.01% -70.32% -37.35% -9.57% -23.01% 477.99% 55.95% -44.55% 123.39% -18.88% -110.72%
Free Cash Flow Firm Growth		 604.99% -33.70% -130.07% -104.61% -125.36% -44.12% 451.47% 647.90% 529.48% 166.12% -99.66%
Invested Capital Growth		 -30.93% -10.41% 13.16% 17.67% 35.01% -1.53% -25.72% -12.20% -24.51% -32.11% -3.05%
Revenue Q/Q Growth		 19.09% -11.98% -10.97% 15.68% 9.12% -12.26% -10.33% 19.62% 14.65% -17.88% -13.71%
EBITDA Q/Q Growth		 29.24% -20.12% -39.81% 62.32% 43.24% -38.74% -47.02% 157.36% 82.72% -77.40% -59.24%
EBIT Q/Q Growth		 45.62% -26.21% -55.76% 132.39% 60.82% -49.58% -72.94% 478.57% 114.89% -91.77% -198.64%
NOPAT Q/Q Growth		 -23.76% -15.70% -64.06% 157.72% 51.24% -28.92% -81.82% 540.71% 108.78% -90.79% -192.79%
Net Income Q/Q Growth		 -22.12% -16.33% -62.74% 162.39% 49.29% -28.79% -81.98% 554.58% 108.98% -90.12% -191.11%
EPS Q/Q Growth		 -29.41% -11.11% -62.50% 166.67% 50.00% -25.00% -83.33% 616.67% 106.98% -89.89% -188.89%
Operating Cash Flow Q/Q Growth		 -21.97% -76.28% 171.49% 79.94% -33.57% 78.10% -26.75% -36.02% 167.61% -35.33% -109.68%
Free Cash Flow Firm Q/Q Growth		 -50.45% -54.11% -137.02% 45.29% -172.80% 201.12% 132.87% -14.71% 113.84% -37.34% -99.70%
Invested Capital Q/Q Growth		 -4.85% 22.45% 8.19% -6.65% 9.18% -10.69% -18.39% 10.33% -6.12% -19.69% 16.55%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 74.95% 76.03% 76.45% 75.91% 76.08% 76.43% 76.38% 76.60% 78.14% 76.30% 76.74%
EBITDA Margin		 15.53% 14.09% 9.53% 13.37% 17.55% 12.25% 7.24% 15.57% 24.82% 6.83% 3.23%
Operating Margin		 10.99% 9.21% 4.58% 9.20% 13.56% 7.79% 2.35% 11.37% 21.31% 2.14% -2.44%
EBIT Margin		 10.99% 9.21% 4.58% 9.20% 13.56% 7.79% 2.35% 11.37% 21.31% 2.14% -2.44%
Profit (Net Income) Margin		 7.08% 6.73% 2.82% 6.39% 8.74% 7.09% 1.42% 7.80% 14.21% 1.71% -1.81%
Tax Burden Percent		 67.38% 76.98% 62.53% 69.35% 65.22% 91.94% 61.77% 68.40% 66.46% 74.42% 79.82%
Interest Burden Percent		 95.57% 94.85% 98.34% 100.12% 98.83% 99.01% 98.13% 100.25% 100.35% 107.59% 92.65%
Effective Tax Rate		 32.62% 23.02% 37.47% 30.65% 34.78% 8.06% 38.23% 31.60% 33.54% 25.58% 0.00%
Return on Invested Capital (ROIC)		 44.93% 41.90% 17.90% 44.33% 59.63% 46.56% 9.92% 53.18% 97.00% 12.77% -14.25%
ROIC Less NNEP Spread (ROIC-NNEP)		 45.61% 42.54% 17.97% 44.32% 59.84% 46.69% 9.96% 53.13% 96.89% 12.56% -14.10%
Return on Net Nonoperating Assets (RNNOA)		 -21.31% -19.81% -9.02% -20.30% -29.01% -21.60% -4.94% -23.35% -46.66% -6.60% 7.35%
Return on Equity (ROE)		 23.62% 22.10% 8.88% 24.03% 30.62% 24.95% 4.98% 29.83% 50.34% 6.16% -6.90%
Cash Return on Invested Capital (CROIC)		 82.24% 55.78% 33.18% 25.93% 13.76% 43.67% 71.71% 57.73% 83.72% 93.01% 54.35%
Operating Return on Assets (OROA)		 11.36% 10.67% 5.41% 11.60% 15.06% 9.55% 2.88% 14.57% 24.13% 2.68% -3.15%
Return on Assets (ROA)		 7.31% 7.79% 3.33% 8.06% 9.71% 8.69% 1.74% 9.99% 16.09% 2.15% -2.33%
Return on Common Equity (ROCE)		 23.62% 22.10% 8.88% 24.03% 30.62% 24.95% 4.98% 29.83% 50.34% 6.16% -6.90%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 21.52% 20.96% 22.21% 0.00% 25.48% 24.14% 25.30% 0.00% 24.47% 24.52%
Net Operating Profit after Tax (NOPAT)		 5.84 4.92 1.77 4.56 6.89 4.90 0.89 5.71 12 1.10 -1.02
NOPAT Margin		 7.41% 7.09% 2.86% 6.38% 8.84% 7.16% 1.45% 7.78% 14.16% 1.59% -1.71%
Net Nonoperating Expense Percent (NNEP)		 -0.68% -0.63% -0.07% 0.02% -0.21% -0.13% -0.04% 0.04% 0.11% 0.21% -0.15%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - 6.39% - - - 1.33% -1.37%
Cost of Revenue to Revenue		 25.05% 23.97% 23.55% 24.09% 23.92% 23.57% 23.62% 23.40% 21.86% 23.70% 23.26%
SG&A Expenses to Revenue		 60.94% 63.45% 68.56% 63.89% 58.96% 64.63% 66.47% 61.48% 53.82% 68.33% 75.63%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 63.96% 66.82% 71.87% 66.71% 62.52% 68.64% 74.03% 65.23% 56.83% 74.16% 79.18%
Earnings before Interest and Taxes (EBIT)		 8.66 6.39 2.83 6.57 11 5.33 1.44 8.34 18 1.48 -1.46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 12 9.78 5.88 9.55 14 8.38 4.44 11 21 4.72 1.92
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.96 8.06 7.13 6.86 7.16 7.41 7.16 6.80 6.34 5.95 5.82
Price to Tangible Book Value (P/TBV)		 97.51 49.27 37.26 299.97 81.39 0.00 410.41 229.90 37.26 39.11 80.55
Price to Revenue (P/Rev)		 2.51 2.66 2.36 1.82 2.01 1.87 1.82 1.75 1.84 1.67 1.47
Price to Earnings (P/E)		 38.37 40.33 36.39 33.71 32.50 29.51 30.65 27.77 22.32 24.35 23.65
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.61% 2.48% 2.75% 2.97% 3.08% 3.39% 3.26% 3.60% 4.48% 4.11% 4.23%
Enterprise Value to Invested Capital (EV/IC)		 17.28 15.59 12.95 10.98 11.14 11.58 13.53 11.89 13.31 14.77 11.35
Enterprise Value to Revenue (EV/Rev)		 2.33 2.49 2.20 1.71 1.90 1.77 1.69 1.63 1.67 1.49 1.34
Enterprise Value to EBITDA (EV/EBITDA)		 16.05 17.50 16.25 12.84 13.69 13.19 13.07 12.05 10.64 10.32 9.84
Enterprise Value to EBIT (EV/EBIT)		 25.84 27.56 25.48 19.66 20.20 19.55 19.71 17.80 14.53 14.66 14.58
Enterprise Value to NOPAT (EV/NOPAT)		 30.94 32.89 30.20 28.16 29.39 27.29 27.33 24.86 20.52 21.81 21.80
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.71 14.98 15.10 12.43 14.90 9.86 8.61 9.49 7.97 7.51 8.95
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.17 26.41 41.43 45.79 93.02 26.33 16.08 19.26 13.67 12.84 20.56
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.16 0.13 0.12 0.12 0.09 0.09 0.07 0.04 0.02 0.02 0.02
Long-Term Debt to Equity		 0.09 0.07 0.05 0.04 0.02 0.02 0.02 0.01 0.01 0.01 0.01
Financial Leverage		 -0.47 -0.47 -0.50 -0.46 -0.48 -0.46 -0.50 -0.44 -0.48 -0.53 -0.52
Leverage Ratio		 3.13 2.73 2.63 2.99 3.13 2.85 2.81 2.99 3.14 3.04 3.09
Compound Leverage Factor		 2.99 2.59 2.59 2.99 3.09 2.82 2.76 3.00 3.15 3.27 2.86
Debt to Total Capital		 13.66% 11.70% 10.45% 10.35% 8.57% 8.01% 6.49% 3.79% 1.90% 1.97% 2.21%
Short-Term Debt to Total Capital		 6.08% 5.75% 5.72% 7.02% 6.78% 5.98% 4.40% 2.78% 0.99% 1.01% 1.13%
Long-Term Debt to Total Capital		 7.58% 5.96% 4.73% 3.33% 1.78% 2.03% 2.08% 1.01% 0.91% 0.96% 1.08%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 86.34% 88.30% 89.55% 89.65% 91.43% 91.99% 93.51% 96.21% 98.10% 98.03% 97.79%
Debt to EBITDA		 0.34 0.31 0.29 0.23 0.19 0.16 0.14 0.08 0.04 0.04 0.04
Net Debt to EBITDA		 -1.24 -1.20 -1.19 -0.82 -0.79 -0.74 -1.00 -0.89 -1.04 -1.25 -1.00
Long-Term Debt to EBITDA		 0.19 0.16 0.13 0.07 0.04 0.04 0.04 0.02 0.02 0.02 0.02
Debt to NOPAT		 0.66 0.58 0.53 0.50 0.41 0.34 0.28 0.15 0.07 0.08 0.09
Net Debt to NOPAT		 -2.40 -2.25 -2.21 -1.80 -1.70 -1.54 -2.09 -1.83 -2.01 -2.63 -2.20
Long-Term Debt to NOPAT		 0.37 0.29 0.24 0.16 0.08 0.09 0.09 0.04 0.03 0.04 0.05
Altman Z-Score		 3.82 4.72 4.52 4.07 3.84 4.04 3.87 3.99 3.75 3.73 3.68
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.01 1.07 1.05 0.91 0.96 0.87 0.88 0.88 0.99 0.97 0.90
Quick Ratio		 0.87 0.90 0.87 0.74 0.79 0.70 0.71 0.71 0.83 0.80 0.70
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 22 9.96 -3.69 -2.02 -5.50 5.56 13 11 24 15 0.04
Operating Cash Flow to CapEx		 1,159.34% 243.31% 583.40% 1,635.85% 1,009.38% 1,626.68% 1,983.54% 906.10% 2,032.71% 1,417.33% -107.54%
Free Cash Flow to Firm to Interest Expense		 54.10 24.28 -9.01 -5.70 -13.42 16.31 39.49 44.73 116.38 83.17 0.29
Operating Cash Flow to Interest Expense		 31.72 7.36 20.03 41.64 23.88 51.14 38.95 33.09 107.74 79.47 -8.78
Operating Cash Flow Less CapEx to Interest Expense		 28.98 4.33 16.59 39.09 21.51 47.99 36.98 29.44 102.44 73.86 -16.94
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.03 1.16 1.18 1.26 1.11 1.23 1.22 1.28 1.13 1.26 1.29
Accounts Receivable Turnover		 3.67 4.97 5.44 5.31 3.63 4.77 5.03 4.85 3.42 4.75 5.18
Inventory Turnover		 20.23 21.10 22.21 17.18 17.32 17.52 17.34 14.41 16.11 16.72 15.87
Fixed Asset Turnover		 24.65 27.03 27.77 29.17 28.28 29.45 30.08 30.67 30.60 31.55 31.34
Accounts Payable Turnover		 6.84 10.34 8.72 8.98 7.72 10.61 8.19 10.00 9.21 11.42 9.06
Days Sales Outstanding (DSO)		 99.46 73.45 67.06 68.69 100.51 76.52 72.50 75.26 106.70 76.87 70.42
Days Inventory Outstanding (DIO)		 18.04 17.30 16.44 21.24 21.07 20.83 21.04 25.32 22.66 21.83 22.99
Days Payable Outstanding (DPO)		 53.35 35.31 41.87 40.64 47.28 34.41 44.54 36.51 39.62 31.95 40.30
Cash Conversion Cycle (CCC)		 64.15 55.43 41.62 49.29 74.31 62.94 49.00 64.07 89.74 66.75 53.12
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 35 43 47 44 48 43 35 38 36 29 34
Invested Capital Turnover		 6.07 5.91 6.25 6.95 6.74 6.50 6.83 6.84 6.85 8.04 8.34
Increase / (Decrease) in Invested Capital		 -16 -5.04 5.45 6.57 12 -0.66 -12 -5.34 -12 -14 -1.06
Enterprise Value (EV)		 612 676 607 481 533 494 471 457 480 428 383
Market Capitalization		 659 722 652 511 563 522 507 491 527 480 422
Book Value per Share		 $5.98 $6.45 $6.57 $5.38 $5.96 $5.25 $5.33 $5.44 $6.35 $6.12 $5.50
Tangible Book Value per Share		 $0.49 $1.05 $1.26 $0.12 $0.52 ($0.01) $0.09 $0.16 $1.08 $0.93 $0.40
Total Capital		 96 101 102 83 86 77 76 75 85 82 74
Total Debt		 13 12 11 8.60 7.37 6.14 4.91 2.85 1.61 1.62 1.64
Total Long-Term Debt		 7.27 6.05 4.82 2.76 1.54 1.56 1.58 0.76 0.78 0.79 0.80
Net Debt		 -47 -46 -44 -31 -31 -28 -36 -34 -47 -52 -39
Capital Expenditures (CapEx)		 1.10 1.24 1.40 0.90 0.97 1.07 0.64 0.90 1.08 1.00 1.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -53 -44 -43 -45 -39 -47 -54 -51 -50 -57 -53
Debt-free Net Working Capital (DFNWC)		 7.92 15 12 -5.84 -0.80 -13 -13 -14 -1.37 -3.92 -12
Net Working Capital (NWC)		 2.09 8.67 5.80 -12 -6.63 -17 -16 -17 -2.20 -4.75 -13
Net Nonoperating Expense (NNE)		 0.26 0.25 0.03 -0.01 0.08 0.05 0.02 -0.01 -0.04 -0.08 0.06
Net Nonoperating Obligations (NNO)		 -47 -46 -44 -31 -31 -28 -36 -34 -47 -52 -39
Total Depreciation and Amortization (D&A)		 3.58 3.38 3.06 2.98 3.11 3.05 3.00 3.08 2.95 3.24 3.38
Debt-free, Cash-free Net Working Capital to Revenue		 -20.01% -16.11% -15.75% -16.05% -13.91% -16.75% -19.20% -18.16% -17.42% -19.87% -18.38%
Debt-free Net Working Capital to Revenue		 3.01% 5.35% 4.21% -2.08% -0.28% -4.60% -4.55% -5.15% -0.48% -1.36% -4.26%
Net Working Capital to Revenue		 0.79% 3.20% 2.10% -4.15% -2.36% -6.24% -5.74% -5.89% -0.77% -1.65% -4.55%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.39 $0.34 $0.13 $0.33 $0.50 $0.37 $0.07 $0.43 $0.91 $0.09 ($0.08)
Adjusted Weighted Average Basic Shares Outstanding		 14.15M 13.88M 13.90M 13.62M 13.64M 13.24M 13.26M 13.16M 13.17M 13.09M 13.10M
Adjusted Diluted Earnings per Share		 $0.36 $0.32 $0.12 $0.32 $0.48 $0.36 $0.06 $0.43 $0.89 $0.09 ($0.08)
Adjusted Weighted Average Diluted Shares Outstanding		 14.56M 14.51M 14.53M 14.27M 14.30M 13.64M 13.48M 13.38M 13.47M 13.27M 13.10M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.90M 13.91M 13.85M 13.20M 13.43M 13.29M 13.27M 13.09M 13.18M 13.20M 12.99M
Normalized Net Operating Profit after Tax (NOPAT)		 5.84 4.92 1.77 4.56 6.89 5.43 2.53 6.19 12 2.57 -1.02
Normalized NOPAT Margin		 7.41% 7.09% 2.86% 6.38% 8.84% 7.94% 4.12% 8.43% 14.16% 3.73% -1.71%
Pre Tax Income Margin		 10.51% 8.74% 4.50% 9.21% 13.40% 7.71% 2.31% 11.40% 21.39% 2.30% -2.26%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 21.60 15.59 6.91 18.57 25.78 15.63 4.40 33.78 88.32 8.29 -9.33
NOPAT to Interest Expense		 14.56 12.00 4.32 12.87 16.81 14.37 2.72 23.10 58.69 6.17 -6.53
EBIT Less CapEx to Interest Expense		 18.87 12.57 3.48 16.02 23.41 12.48 2.43 30.13 83.01 2.68 -17.49
NOPAT Less CapEx to Interest Expense		 11.82 8.98 0.89 10.33 14.45 11.23 0.75 19.45 53.39 0.56 -14.69
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 129.41% 109.91% 130.47% 179.32% 199.96% 284.04% 288.32% 173.77% 131.39% 103.36% 151.81%

Financials Breakdown Chart

Key Financial Trends

Here are concise, investor-focused takeaways on Franklin Covey (FC) drawn from the four most recent years of quarterly statements provided. The bullets below are organized from potential positive to neutral to negative impacts, to help readers quickly gauge the trend and potential catalysts.

  • Q4 2024 showed a revenue peak for FC, with Operating Revenue and Total Revenue of $84,125,000 and Total Gross Profit of $65,738,000, yielding a gross margin around 78%.
  • Net income attributable to common shareholders was positive in multiple quarters, notably Q4 2024 at $12,438,000 and Q3 2024 at $5,546,000, signaling periods of meaningful profitability recovery.
  • Operating cash flow has been robust across several quarters, with net cash from continuing operating activities of about $21,872,000 in Q4 2024, $12,774,000 in Q2 2024, and $17,438,000 in Q1 2024, indicating strong cash generation from core operations.
  • Gross margins have remained solid in the mid-70s to high-70s range across recent quarters (e.g., Q4 2024 around 78%; Q2 2025 about 77%; Q1 2025 about 76%), suggesting favorable product pricing and cost control.
  • The balance sheet shows a solid equity base and relatively modest leverage, with total equity generally in the $72–81 million range and only modest debt (short-term and long-term debt typically in the low single-digit millions), supporting a stable capital structure.
  • Revenue demonstrates seasonality, with FC often posting weaker results in mid-year quarters (e.g., Q2 2025 revenue around $59.6 million versus higher levels in Q4 2024), indicating quarterly cyclicality rather than a steady uptrend.
  • Current liabilities include a large current deferred revenue balance (approximately $88 million in several periods), which can skew near-term liquidity metrics and requires attentive revenue recognition timing.
  • Intangible assets and goodwill are substantial (intangible assets around $36–46 million and goodwill near $31 million), signaling a history of acquisitions but also potential impairment risk if growth slows or margins erode.
  • FC posted a quarterly net loss in Q2 2025, with net income (consolidated) around negative $1.08 million and negative cash flow from continuing operating activities (~$1.37 million), highlighting a period of weakened profitability and cash generation.
  • Near-term liquidity pressures exist in some quarters, as reflected by current assets ($121 million in Q2 2025) versus current liabilities ($134 million in Q2 2025), implying a current ratio nearing 0.9 and a tighter short-term liquidity position.
05/14/26 03:27 PM ETAI Generated. May Contain Errors.

Franklin Covey Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Franklin Covey's financial year ends in August. Their financial year 2024 ended on August 31, 2024.

Franklin Covey's net income appears to be on an upward trend, with a most recent value of $23.40 million in 2024, rising from $18.43 million in 2022. The previous period was $17.78 million in 2023. See Franklin Covey's forecast for analyst expectations on what's next for the company.

Franklin Covey's total operating income in 2024 was $33.04 million, based on the following breakdown:
  • Total Gross Profit: $221.07 million
  • Total Operating Expenses: $188.03 million

Over the last 2 years, Franklin Covey's total revenue changed from $262.84 million in 2022 to $287.23 million in 2024, a change of 9.3%.

Franklin Covey's total liabilities were at $178.40 million at the end of 2024, a 6.7% increase from 2023, and a 1.2% increase since 2022.

In the past 2 years, Franklin Covey's cash and equivalents has ranged from $38.23 million in 2023 to $60.52 million in 2022, and is currently $48.66 million as of their latest financial filing in 2024.

Over the last 2 years, Franklin Covey's book value per share changed from 5.98 in 2022 to 6.35 in 2024, a change of 6.2%.


Related Companies

Financial statements for NYSE:FC last updated on 4/21/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Is this AI lab Elon’s SpaceX lifeline?
Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...
Chaikin Analytics | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Millionaire warns: Move your money before May 15
Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...
Brownstone Research | Sponsoredtc pixel